Laura is the vice president of content for The American Journal of Managed Care® (AJMC®) and all its brands, including Population Health, Equity & Outcomes; Evidence-Based Oncology™; and The Center for Biosimilars®. She has been working on AJMC since 2014 and has been with AJMC’s parent company, MJH Life Sciences®, since 2011.
She has an MA in business and economic reporting from New York University. You can connect with Laura on LinkedIn or Twitter.
Tom Price Is Confirmed as HHS Secretary, Will Lead ACA Repeal
Early in the morning on Friday, the Senate voted along party lines (52-47) to confirm US Rep. Tom Price, R-Georgia, as secretary of HHS. President Donald Trump nominated Price with the expectation that he will lead the charge to repeal and replace the Affordable Care Act.
5 Things to Know About Block Grants in Medicaid
Now that the Senate has confirmed US Rep. Tom Price, R-Georgia, as HHS secretary, Republicans will start to look toward making changes to the Affordable Care Act and Medicaid. Here is a look at block grants, which the GOP is considering using to reform the Medicaid program.
Anthem-Cigna Merger Blocked; Judge Cites Anticompetitive Effects
A judge has blocked the proposed merger of Anthem and Cigna, saying consolidation would likely result in higher prices and have other anticompetitive effects. The ruling comes just 2 weeks after another judge blocked the Aetna-Humana merger.
Implementing Alternative Payment Models: Just Do It, Advocate Panelists at AcademyHealth
Payment reform in the United States has been going on for years, and a panel at the AcademyHealth National Health Policy Conference analyzed how much progress has been made to move away from fee-for-service, and what the evidence on alternative payment models has found.
FOURIER Study Finds Repatha Reduces Risk of Cardiovascular Events
Amgen's Repatha was shown to reduce the risk of cardiovascular events, such as cardiovascular death and myocardial infarction, in phase 3 of the FOURIER study. Full results will be presented in March 2017 at the American College of Cardiology 66th Scientific Sessions.
Analysis Finds Alemtuzumab Most Cost-Effective Treatment for Multiple Sclerosis
A review of 15 disease-modifying therapies (DMTs) for the treatment of relapsing-remitting and primary-progressive multiple sclerosis (MS) has found that prices for most of these drugs are not well-aligned with added value for patients.
Medicare's VBP Has Led to Little Meaningful Gains in Patient Experience
CMS has tried to improve patient experience by tying payments to performance as part of the Value-Based Purchasing (VBP) program; however, a paper published in Health Affairs found no evidence that the program has had a beneficial effect.
Rand Paul's ACA Replacement Relies on HSAs and Selling Across State Lines
Senator Rand Paul, R-Kentucky, provides his plan to replace the Affordable Care Act, which includes expanding the use of health savings accounts and allowing health insurance to be sold and purchased across state lines.
Cassidy, Collins Unveil Details to ACA Replacement Proposal
A new healthcare reform legislation was introduced Monday by Bill Cassidy, MD, R-Louisiana, and Susan Collins, R-Maine. The proposed Patient Freedom Act would not fully repeal the Affordable Care Act (ACA), but instead, would place more power in the hands of the states by giving them the option of staying with the ACA or choosing another option.
Missed Opportunity to Test Patients With Severe Mental Illness for HIV
Despite being up to 15 times more likely to be HIV positive, people with bipolar disorder, schizophrenia, and major depression with psychosis aren’t much more likely than the general population to be tested for the virus.
Nearly Half of New Drugs Approved in 2016 Were Orphan Drugs
Among the 9 new orphan drugs approved by the FDA in 2016 were 3 treatments for rare diseases that, so far, had no approved treatments: Duchenne muscular dystrophy, spinal muscular atrophy, and severe hepatic veno-occlusive disease.
A Better Way to Cover High-Value Services
Rising healthcare expenditures, leading to increased consumer cost sharing, is a top concern in healthcare that crosses party lines. In a new commentary in JAMA Internal Medicine, A. Mark Fendrick, MD, and Michael E. Chernew, PhD, co-editors-in-chief of The American Journal of Managed Care, highlighted the need for a “smarter” deductible.
5 Key Takeaways From CMS' Andy Slavitt
As the team at CMS prepares to hand the reins over to the next administration, Andy Slavitt, acting administrator of CMS, took the time to speak with Mandi Bishop, MA, CEO of Aloha Health, in the latest podcast of Managed Care Cast about what he learned in his role and what the next administration should keep in mind.
The High Cost of Home Care for Children With Special Healthcare Needs
Caring at home for children with special healthcare needs brings high costs to families. A study by researchers at the University of Southern California, Boston Children’s Hospital, and RAND Corp., placed the uncompensated medical cost at nearly $36 billion annually.
Identifying the Inability to Heal Lungs in COPD
Although chronic obstructive pulmonary disease (COPD) remains a leading cause of death around the world, the reason for why patients with COPD lose the ability to repair damage to their lungs is poorly defined. However, researchers at the Helmholtz Zentrium München may now have an idea of why this happens.